It can inhibit the production of inflammatory factors and the activation of signaling pathways, thereby reducing redness, itching, and discomfort caused by inflammation
However, reduced effectiveness is its own kind of waste
doi: 10.3389/fphar.2024.1457363 Received 30 June 2024 Accepted 22 August 2024 Published 04 September 2024 Volume 15 - 2024 Edited by Karuna Rasineni, University of Nebraska Medical Center, United States Reviewed by Luigi Losco, University of Salerno, Italy Sundararajan Mahalingam, University of Nebraska Omaha, United States Updates Copyright 2024 Brown, Tadros, Montagna, Bell, Crowley, Gallagher and Dayan
The American Society of Anesthesiologists recommended in June 2023 that patients stop taking GLP-1 agonists a week before elective surgeries, due to the increased risk of vomiting during surgery, while CNN reported in July other accounts of patients taking Ozempic and Wegovy suffering gastroparesis, with some claiming to have vomited days-old food
